ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 20 filers reported holding ZOSANO PHARMA CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $343,000 | – | 72,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,600,000 | $7,632,000 | 5.81% |
| Telemetry Investments, L.L.C. | 242,826 | $1,158,000 | 0.59% |
| MYDA Advisors LLC | 72,000 | $343,000 | 0.17% |
| Highlander Capital Management, LLC | 10,000 | $48,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $4,770,000 | 0.01% |
| Hartford Financial Management Inc. | 2,000 | $10,000 | 0.00% |
| GABELLI FUNDS LLC | 21,297 | $102,000 | 0.00% |
| IFP Advisors, Inc | 1,248 | $6,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 81,829 | $390,000 | 0.00% |
| DEUTSCHE BANK AG\ | 100 | $0 | 0.00% |